Scholarlink

<p>This study aimed to assess the incremental prognostic value of ischemic score quantified by stress dynamic CT myocardial perfusion imaging (CT-MPI) in patients with and without diabetes mellitus (DM). 331 patients (92 patients with DM) with suspected coronary artery disease (CAD) who underwent coronary computed tomography angiography (CCTA) and CT-MPI were included. Major adverse cardiovascular events (MACE) included cardiac death, acute coronary syndrome (ACS), late revascularization, and hospitalizations attributable to heart failure. Ischemic score was assessed based on reduced myocardial blood flow across 16 segments. An ischemic perfusion defect (IPD) was identified as ischemic score ≥ 4. During a median follow-up of 15 (9, 40) months, 49 patients (14.8%) experienced MACE. IPD was an independent predictor for the development of MACE in both DM (HR: 11.64, <i>p</i> = 0.019) and non-DM patient groups (HR: 8.66, <i>p</i> = 0.004). Adding IPD to clinical risk factors and CCTA characteristics increased the C-index for predicting MACE from 0.72 to 0.80 in DM patients (<i>p</i> = 0.005) and from 0.76 to 0.83 in non-DM patients (<i>p</i> = 0.006). IPD quantified by stress dynamic CT-MPI had incremental prognostic value over traditional clinical risk factors and anatomic parameters in both DM and non-DM patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Incremental prognostic value of ischemic score quantified by stress dynamic CT myocardial perfusion in patients with and without diabetes mellitus

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月5日

查看全文
  • Xiaoling Tao,
  • Xueyan Hou,
  • Qingshuang Liu,
  • Shuang Pan,
  • Xueqin Jiang,
  • Mengnan Zhang,
  • Ruili Qin,
  • Hao Wang,
  • Zhaoqian Wang

摘要

This study aimed to assess the incremental prognostic value of ischemic score quantified by stress dynamic CT myocardial perfusion imaging (CT-MPI) in patients with and without diabetes mellitus (DM). 331 patients (92 patients with DM) with suspected coronary artery disease (CAD) who underwent coronary computed tomography angiography (CCTA) and CT-MPI were included. Major adverse cardiovascular events (MACE) included cardiac death, acute coronary syndrome (ACS), late revascularization, and hospitalizations attributable to heart failure. Ischemic score was assessed based on reduced myocardial blood flow across 16 segments. An ischemic perfusion defect (IPD) was identified as ischemic score ≥ 4. During a median follow-up of 15 (9, 40) months, 49 patients (14.8%) experienced MACE. IPD was an independent predictor for the development of MACE in both DM (HR: 11.64, p = 0.019) and non-DM patient groups (HR: 8.66, p = 0.004). Adding IPD to clinical risk factors and CCTA characteristics increased the C-index for predicting MACE from 0.72 to 0.80 in DM patients (p = 0.005) and from 0.76 to 0.83 in non-DM patients (p = 0.006). IPD quantified by stress dynamic CT-MPI had incremental prognostic value over traditional clinical risk factors and anatomic parameters in both DM and non-DM patients.